7-demethylsuberosin CAS 21422-04-8
Introduction:Basic information about 7-demethylsuberosin CAS 21422-04-8, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
7-demethylsuberosin Basic information
| Product Name: | 7-demethylsuberosin |
| Synonyms: | 7-demethylsuberosin;2H-1-Benzopyran-2-one,7-hydroxy-6-(3-Methyl-2-buten-1-yl)-;6-(Dimethylallyl)umbelliferone;7-hydroxy-6-(3-methylbut-2-enyl)chromen-2-one;Demethylsuberosin, 10 mM in DMSO;7-Hydroxy-6-(3-methylbut-2-en-1-yl)-2H-chromen-2-one |
| CAS: | 21422-04-8 |
| MF: | C14H14O3 |
| MW: | 230.26 |
| EINECS: | |
| Product Categories: | |
| Mol File: | 21422-04-8.mol |
7-demethylsuberosin Chemical Properties
| Melting point | 134-136℃ |
| Boiling point | 418.8±45.0 °C(Predicted) |
| density | 1.203±0.06 g/cm3(Predicted) |
| solubility | DMSO: 250 mg/ml |
| form | A solid |
| pka | 8.45±0.20(Predicted) |
| color | White to off-white |
| InChI | InChI=1S/C14H14O3/c1-9(2)3-4-10-7-11-5-6-14(16)17-13(11)8-12(10)15/h3,5-8,15H,4H2,1-2H3 |
| InChIKey | FIDUIAPDSKSUGO-UHFFFAOYSA-N |
| SMILES | C1(=O)OC2=CC(O)=C(C/C=C(/C)\C)C=C2C=C1 |
Safety Information
| Chemical Properties | Yellow crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO. It comes from Korean Angelica sinensis and the Dai medicine Tripterygium wilfordii. |
| Uses | Demethylsuberosin (7-Demethylsuberosin) is a coumarin compound isolated from Angelica gigas Nakai, and has anti-inflammatory activity[1]. |
| Definition | ChEBI: A natural product found in Citropsis articulata. |
| References | [1] Yongfen Ma, et al. Anti-inflammatory Activities of Coumarins Isolated from Angelica gigas Nakai on LPS-stimulated RAW 264.7 Cells. J Food Sci Nutr Vol 14, p 179~187 (2009). [2] Yang X, et al. Angelica decursiva exerts antihypertensive activity by inhibiting L-type calcium channel. J Ethnopharmacol. 2023 Sep 15;313:116527. [3] Kang SY, et al. Neuroprotective coumarins from the root of Angelica gigas: structure-activity relationships. Arch Pharm Res. 2007 Nov;30(11):1368-73. DOI:10.1007/BF02977358 |
